New cathinone-derived designer drugs 3-bromomethcathinone and 3-fluoromethcathinone: studies on their metabolism in rat urine and human liver microsomes using GC-MS and LC-high-resolution MS and their detectability in urine.
about
Ketamine-derived designer drug methoxetamine: metabolism including isoenzyme kinetics and toxicological detectability using GC-MS and LC-(HR-)MSn2-methiopropamine, a thiophene analogue of methamphetamine: studies on its metabolism and detectability in the rat and human using GC-MS and LC-(HR)-MS techniques.The in vivo and in vitro metabolism and the detectability in urine of 3',4'-methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP), a new pyrrolidinophenone-type designer drug, studied by GC-MS and LC-MS(n.).Qualitative metabolism assessment and toxicological detection of xylazine, a veterinary tranquilizer and drug of abuse, in rat and human urine using GC-MS, LC-MSn, and LC-HR-MSn.Lefetamine-derived designer drugs N-ethyl-1,2-diphenylethylamine (NEDPA) and N-iso-propyl-1,2-diphenylethylamine (NPDPA): metabolism and detectability in rat urine using GC-MS, LC-MSn and LC-HR-MS/MS.UPLC/ESI-MS/MS-based determination of metabolism of several new illicit drugs, ADB-FUBINACA, AB-FUBINACA, AB-PINACA, QUPIC, 5F-QUPIC and α-PVT, by human liver microsome.Benzofuran analogues of amphetamine and methamphetamine: studies on the metabolism and toxicological analysis of 5-APB and 5-MAPB in urine and plasma using GC-MS and LC-(HR)-MS(n) techniques.Metabolism of the new psychoactive substances N,N-diallyltryptamine (DALT) and 5-methoxy-DALT and their detectability in urine by GC-MS, LC-MSn, and LC-HR-MS-MS.Discriminative and locomotor effects of five synthetic cathinones in rats and miceSynthetic cathinone abuseKhat and synthetic cathinones: a review.Toxicology and management of novel psychoactive drugs.Recent developments in urinalysis of metabolites of new psychoactive substances using LC-MS.Updating the list of known opioids through identification and characterization of the new opioid derivative 3,4-dichloro-N-(2-(diethylamino)cyclohexyl)-N-methylbenzamide (U-49900).Synthetic cathinone pharmacokinetics, analytical methods, and toxicological findings from human performance and postmortem cases.Case report of accidental poisoning with the tranquilizer xylazine and the anesthetic ketamine confirmed by qualitative and quantitative toxicological analysis using GC-MS and LC-MS(n.).Presence and composition of cathinone derivatives in drug samples taken from a drug test service in Spain (2010-2012).Studies on the metabolism and detectability of the emerging drug of abuse diphenyl-2-pyrrolidinemethanol (D2PM) in rat urine using GC-MS and LC-HR-MS/MS.Simultaneous quantification of 28 synthetic cathinones and metabolites in urine by liquid chromatography-high resolution mass spectrometry.Formation of odd-electron product ions in collision-induced fragmentation of electrospray-generated protonated cathinone derivatives: aryl α-primary amino ketones.GC-MS, LC-MS(n), LC-high resolution-MS(n), and NMR studies on the metabolism and toxicological detection of mesembrine and mesembrenone, the main alkaloids of the legal high "Kanna" isolated from Sceletium tortuosum.A new approach towards biomarker selection in estimation of human exposure to chiral chemicals: a case study of mephedrone.Characterizing metabolites and potential metabolic pathways for the novel psychoactive substance methoxetamine.Dimethocaine, a synthetic cocaine analogue: studies on its in-vivo metabolism and its detectability in urine by means of a rat model and liquid chromatography-linear ion-trap (high-resolution) mass spectrometry.Toxicokinetics of new psychoactive substances: plasma protein binding, metabolic stability, and human phase I metabolism of the synthetic cannabinoid WIN 55,212-2 studied using in vitro tools and LC-HR-MS/MS.Biotransformation and detectability of the new psychoactive substances N,N-diallyltryptamine (DALT) derivatives 5-fluoro-DALT, 7-methyl-DALT, and 5,6-methylenedioxy-DALT in urine using GC-MS, LC-MSn, and LC-HR-MS/MS.Toxicology of Specific Substances
P2860
Q28292983-D416429B-D419-4228-A36C-74F9ED667D3EQ34325128-98383337-864D-4FC5-8CD5-CE00C34E5FC2Q34377572-3AAD3D92-9337-40E0-9467-ABC19527A57CQ34378886-FC7790C4-BEAA-49BA-BA13-C1DB9D59146AQ34408021-55B862C2-0289-4770-A384-62DD1AD254CBQ34421396-8BD8B50C-7274-40A0-8068-FBDE254306BAQ34451894-B2D0E577-DC93-4EA2-9168-260F509A2564Q34490537-DB87FDCA-02CB-4E9D-B3CB-75A417AA192FQ35181582-CDCBC6BE-B1A0-44B4-A2DF-FAB24B20845CQ36996570-50211070-A9BF-4C5D-9D31-CF418353B36EQ38169542-171D66A9-5378-4443-9F20-4165936C8346Q38254814-88B0055D-DDC4-4312-B338-241F54C02880Q38260819-5B9535BF-36C0-45BA-A4A6-4D7A92C556C6Q38652427-B8D43E73-E318-4F93-92A3-D49F18141A7FQ38850097-448CF43D-8013-4F3D-AACC-107ED39360CAQ43878945-B761E2B8-538C-4E9A-9CC2-BF1EE9D3CE86Q44665582-BDD98F6F-B09E-4789-961A-12F6043ED588Q44806049-077F0149-8DAD-46F8-A802-8C89D7E370D8Q45219952-F613138F-75E0-42D6-9B7C-08EC5A488C53Q46475968-DE24AFC9-4B17-44F2-B10A-A0D4E9833F98Q46836046-AD95D04E-5425-4D3E-9CFD-A05B94E654F8Q47665629-E65F05EF-A895-48BA-8F6B-909043BCF701Q47907013-0319D7C2-5390-4F99-AC8E-EB8916A5F427Q47921568-9C35B631-2CD3-4D2A-9B64-0901C40E79E1Q52887320-4C29ECDD-B81B-4525-AD82-EE4ACD405C3EQ53641072-FFB6A841-8BA9-4112-B038-D87150636A8CQ57986556-AA1B7AC9-62CA-469A-9063-451CE857A734
P2860
New cathinone-derived designer drugs 3-bromomethcathinone and 3-fluoromethcathinone: studies on their metabolism in rat urine and human liver microsomes using GC-MS and LC-high-resolution MS and their detectability in urine.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
New cathinone-derived designer ...... their detectability in urine.
@ast
New cathinone-derived designer ...... their detectability in urine.
@en
New cathinone-derived designer ...... their detectability in urine.
@nl
type
label
New cathinone-derived designer ...... their detectability in urine.
@ast
New cathinone-derived designer ...... their detectability in urine.
@en
New cathinone-derived designer ...... their detectability in urine.
@nl
prefLabel
New cathinone-derived designer ...... their detectability in urine.
@ast
New cathinone-derived designer ...... their detectability in urine.
@en
New cathinone-derived designer ...... their detectability in urine.
@nl
P2093
P2860
P356
P1476
New cathinone-derived designer ...... their detectability in urine.
@en
P2093
Andrea E Schwaninger
Christian Vollmar
Hans H Maurer
Markus R Meyer
P2860
P304
P356
10.1002/JMS.2960
P577
2012-02-01T00:00:00Z